CIRM: US$44 million investment in treatments for stroke

Written by California Institute for Regenerative Medicine (CIRM)

Two projects aimed at helping people who have had a stroke, plus a therapy that hopes to correct a fatal blood disorder by operating on a baby in the womb, are among the programs approved today by the governing Board of the California Institute for Regenerative Medicine (CIRM). The Board also honored C. Randal Mills, Ph.D., President and CEO of CIRM, and James Harrison, CIRM’s General Counsel, both of whom are leaving the agency. But first, the science. Every year around 800,000 Americans suffer a stroke; 130,000 people die; and for those who survive, strokes are the leading cause of...

To view this content, please register now for access

It's completely free